Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1858 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome

Rueda N, Flórez J, Dierssen M, Martínez-Cué C.

Prog Brain Res. 2020;251:245-268. doi: 10.1016/bs.pbr.2019.10.001. Epub 2019 Nov 1.

Delirium superimposed on dementia

Morandi A, Bellelli G.

Eur Geriatr Med. 2020 Feb;11(1):53-62. doi: 10.1007/s41999-019-00261-6. Epub 2019 Nov 14.

Beta-carotene, telomerase activity and Alzheimer's disease in old age subjects

Boccardi V, Arosio B, Cari L, Bastiani P, Scamosci M, Casati M, Ferri E, Bertagnoli L, Ciccone S, Rossi PD, Nocentini G, Mecocci P.

Eur J Nutr. 2020 Feb;59(1):119-126. doi: 10.1007/s00394-019-01892-y. Epub 2019 Jan 16.

Mechanistic complexities of bone loss in Alzheimer's disease: a review

Frame G, Bretland KA, Dengler-Crish CM.

Connect Tissue Res. 2020 Jan;61(1):4-18. doi: 10.1080/03008207.2019.1624734. Epub 2019 Jun 11.

Selenoprotein P and its potential role in Alzheimer's disease

Solovyev N.

Hormones (Athens). 2020 Mar;19(1):73-79. doi: 10.1007/s42000-019-00112-w. Epub 2019 Jun 27.

Transcranial magnetic stimulation: Emerging biomarkers and novel therapeutics in Alzheimer's disease

Koch G, Martorana A, Caltagirone C.

Neurosci Lett. 2020 Feb 6;719:134355. doi: 10.1016/j.neulet.2019.134355. Epub 2019 Jun 28.

A meta-analysis on CSF neurogranin levels for the diagnosis of Alzheimer's disease and mild cognitive impairment

Mavroudis IA, Petridis F, Chatzikonstantinou S, Kazis D.

Aging Clin Exp Res. 2020 Sep;32(9):1639-1646. doi: 10.1007/s40520-019-01326-z. Epub 2019 Aug 28.

Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis

Xie B, Zhou H, Liu W, Yu W, Liu Z, Jiang L, Zhang R, Cui D, Shi Z, Xu S.

Int J Neurosci. 2020 Mar;130(3):218-230. doi: 10.1080/00207454.2019.1667794. Epub 2019 Sep 24.

Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation

Ruthirakuhan M, Herrmann N, Andreazza AC, Verhoeff NPLG, Gallagher D, Black SE, Kiss A, Lanctôt KL.

J Geriatr Psychiatry Neurol. 2020 Jul;33(4):175-184. doi: 10.1177/0891988719874118. Epub 2019 Sep 23.

Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer's disease: Where do we stand?

Veerabhadrappa B, Delaby C, Hirtz C, Vialaret J, Alcolea D, Lleó A, Fortea J, Santosh MS, Choubey S, Lehmann S.

Crit Rev Clin Lab Sci. 2020 Mar;57(2):99-113. doi: 10.1080/10408363.2019.1678011. Epub 2019 Oct 29.

Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer's Disease: Present and future applications

Reale M, Gonzales-Portillo I, Borlongan CV.

Brain Res. 2020 Jan 15;1727:146535. doi: 10.1016/j.brainres.2019.146535. Epub 2019 Oct 25.

N-terminal tau truncation in the pathogenesis of Alzheimer's disease (AD): Developing a novel diagnostic and therapeutic approach

Amadoro G, Latina V, Corsetti V, Calissano P.

Biochim Biophys Acta Mol Basis Dis. 2020 Mar 1;1866(3):165584. doi: 10.1016/j.bbadis.2019.165584. Epub 2019 Oct 29.

Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer's disease: A literature review

Wesenhagen KEJ, Teunissen CE, Visser PJ, Tijms BM.

Crit Rev Clin Lab Sci. 2020 Mar;57(2):86-98. doi: 10.1080/10408363.2019.1670613. Epub 2019 Nov 7.

Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4(-/-): A double-blind, randomized, placebo-controlled crossover trial

Xu Q, Zhang Y, Zhang X, Liu L, Zhou B, Mo R, Li Y, Li H, Li F, Tao Y, Liu Y, Xue C.

Clin Nutr. 2020 Jul;39(7):2092-2105. doi: 10.1016/j.clnu.2019.10.017. Epub 2019 Oct 22.

Deep learning to detect Alzheimer's disease from neuroimaging: A systematic literature review

Ebrahimighahnavieh MA, Luo S, Chiong R.

Comput Methods Programs Biomed. 2020 Apr;187:105242. doi: 10.1016/j.cmpb.2019.105242. Epub 2019 Nov 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias